Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide Autogel in idiopathic pulmonary fibrosis
2011-003687-78Phase 2Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Mar 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of lanreotide in idiopathic pulmonary fibrosis (IPF) (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Pulmonary function stabilization or improvement. Started Mar 2012; status: completed.
02
Drugs
lanreotide
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on 2011-003687-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003687-78.